Aspirin exclusion in patients with an LVAD

Nature Reviews Cardiology, Published online: 27 November 2023; doi:10.1038/s41569-023-00965-0Data from the ARIES-HM3 trial show that excluding aspirin from the antithrombotic regimen in patients with advanced heart failure and a left ventricular assist device reduces the number of bleeding events and does not increase the risk of thromboembolism.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Source Type: research